help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2007-0768
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pagano, C.
Right arrow Articles by Vettor, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pagano, C.
Right arrow Articles by Vettor, R.
Related Collections
Right arrow Diabetes and Insulin
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 12 4810-4819
Copyright © 2007 by The Endocrine Society

The Endogenous Cannabinoid System Stimulates Glucose Uptake in Human Fat Cells via Phosphatidylinositol 3-Kinase and Calcium-Dependent Mechanisms

Claudio Pagano, Catia Pilon, Alessandra Calcagno, Riccardo Urbanet, Marco Rossato, Gabriella Milan, Katiuscia Bianchi, Rosario Rizzuto, Paolo Bernante, Giovanni Federspil and Roberto Vettor

Endocrine-Metabolic Laboratory (C.Pa., C.Pi., A.C., R.U., M.R., G.M., G.F., R.V.) and Institute of Surgical Pathology (P.B.), Department of Medical and Surgical Sciences, University of Padova, 35128 Padova, Italy; and Section of General Pathology (K.B., R.R.), Department of Experimental and Diagnostic Medicine, University of Ferrara, 44100 Ferrara, Italy

Address all correspondence and requests for reprints to: Dr. Claudio Pagano, M.D., Ph.D., Endocrine-Metabolic Laboratory, Department of Medical and Surgical Sciences, University of Padova, Via Ospedale 105, 35100 Padova, Italy. E-mail: claudio.pagano{at}unipd.it.

Background: The endogenous cannabinoid system participates in the regulation of energy balance, and its dysregulation may be implicated in the pathogenesis of obesity. Adipose tissue endocannabinoids may produce metabolic and endocrine effects, but very few data are available in human adipose tissue and in primary human fat cells.

Experimental Design: We measured expression of type 1 and type 2 cannabinoid receptors (CNR), enzymes of cannabinoids synthesis and degradation in human omental, sc abdominal, and gluteal adipose tissue from lean and obese subjects. Furthermore, we assessed the effect of CNR1 stimulation on glucose uptake and intracellular transduction mechanisms in primary human adipocytes. Then we assessed the reciprocal regulation between CNR1 and peroxisome proliferator-activated receptor-{gamma} (PPAR{gamma}). Finally, we tested whether leptin and adiponectin are regulated by CNR1 in human adipocytes.

Results: We found that most genes of the endocannabinoid system are down-regulated in gluteal fat and up-regulated in visceral and sc abdominal adipose tissue of obese patients. Treatment of adipocytes with rosiglitazone markedly down-regulated CNR1 expression, whereas Win 55,212 up-regulated PPAR{gamma}. Win 55,212 increased (+50%) glucose uptake, the translocation of glucose transporter 4, and intracellular calcium in fat cells. All these effects were inhibited by SR141716 and wortmannin and by removing extracellular calcium. Win 55,212 and SR141716 had no effect on expression of adiponectin and leptin.

Conclusions: These results indicate a role for the local endocannabinoids in the regulation of glucose metabolism in human adipocytes and suggest a role in channeling excess energy fuels to adipose tissue in obese humans.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
H. Butler and M. Korbonits
Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists
Eur. J. Endocrinol., November 1, 2009; 161(5): 655 - 662.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Taube, K. Eckardt, and J. Eckel
Role of lipid-derived mediators in skeletal muscle insulin resistance
Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1004 - E1012.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Flamment, N. Gueguen, C. Wetterwald, G. Simard, Y. Malthiery, and P.-H. Ducluzeau
Effects of the cannabinoid CB1 antagonist rimonabant on hepatic mitochondrial function in rats fed a high-fat diet
Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1162 - E1170.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
B. Batetta, M. Griinari, G. Carta, E. Murru, A. Ligresti, L. Cordeddu, E. Giordano, F. Sanna, T. Bisogno, S. Uda, et al.
Endocannabinoids May Mediate the Ability of (n-3) Fatty Acids to Reduce Ectopic Fat and Inflammatory Mediators in Obese Zucker Rats
J. Nutr., August 1, 2009; 139(8): 1495 - 1501.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. D. de Kloet and S. C. Woods
Endocannabinoids and Their Receptors as Targets for Obesity Therapy
Endocrinology, June 1, 2009; 150(6): 2531 - 2536.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. M. Richey, O. O. Woolcott, D. Stefanovski, L. N. Harrison, D. Zheng, M. Lottati, I. R. Hsu, S. P. Kim, M. Kabir, K. J. Catalano, et al.
Rimonabant prevents additional accumulation of visceral and subcutaneous fat during high-fat feeding in dogs
Am J Physiol Endocrinol Metab, June 1, 2009; 296(6): E1311 - E1318.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Kunos, D. Osei-Hyiaman, J. Liu, G. Godlewski, and S. Batkai
Endocannabinoids and the Control of Energy Homeostasis
J. Biol. Chem., November 28, 2008; 283(48): 33021 - 33025.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Nogueiras, C. Veyrat-Durebex, P. M. Suchanek, M. Klein, J. Tschop, C. Caldwell, S. C. Woods, G. Wittmann, M. Watanabe, Z. Liposits, et al.
Peripheral, but Not Central, CB1 Antagonism Provides Food Intake-Independent Metabolic Benefits in Diet-Induced Obese Rats
Diabetes, November 1, 2008; 57(11): 2977 - 2991.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. W. Herling, S. Kilp, R. Elvert, G. Haschke, and W. Kramer
Increased Energy Expenditure Contributes More to the Body Weight-Reducing Effect of Rimonabant than Reduced Food Intake in Candy-Fed Wistar Rats
Endocrinology, May 1, 2008; 149(5): 2557 - 2566.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society